Tag: biomarkers
-
Diagnostic Company to Partner with Scripps on Drug Discovery
Molecular Response, a diagnostic services company in San Diego, California says it has an agreement with Scripps Genomic Medicine, part of the Scripps Translational Science Institute also in San Diego, for joint discovery of oncology and cardiovascular drugs. Molecular Response develops molecular diagnostics as a companion to targeted and personalized therapeutics. Under the terms of…
-
Diagnostics Companies Get European Grant for Bladder Cancer
Molecular diagnostics companies MDxHealth SA in Liege, Belgium and NovioGendix B.V. in Nijmegen, Netherlands have received a $1.1 million grant from Eurotrans-Bio to advance their bladder cancer program. NovioGendix is a spin-off company from Radboud University Nijmegen Medical Centre (RUNMC). Eurotrans-Bio is a European Commission initiative to encourage cross-border research and development between small companies…
-
Bristol-Myers Squibb, Biotech Partner on Alzheimer’s Test
Opko Health Inc., a biotechnology company in Miami, Florida, said today it has a collaboration agreement with the drug manufacturer Bristol-Myers Squibb Company for Opko’s diagnostic test technology. Opko’s blood tests are being developed from its technology that identifies biomarkers for a range of diseases including neurodegenerative disorders. Part of the project calls for Opko…
-
GE, Sloan-Kettering to Study Early Stage Colon Cancer
A team of scientists at GE Global Research, the technology development arm of the manufacturing and finance company GE, has begun a study with Memorial Sloan-Kettering Cancer Center (MSKCC) in New York, N.Y., to better understand the early stages of colon cancer. The goal is to yield new insights that improve treatment selection and outcomes…